SCHEMBL861622

SCHEMBL861622

OC=CCN1CCCCC1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.39
CHRNB4 P30926 1/20 0.39
CHRNA3 P32297 1/20 0.39
CHRNA4 P43681 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
LTA4H P09960 1/20 0.36
HRH3 Q9Y5N1 3/20 0.36
MAPT P10636 2/20 0.36
ALDH1A1 P00352 2/20 0.34
GAA P10253 1/20 0.34
POLB P06746 1/20 0.34
HSD17B10 Q99714 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
LMNA P02545 1/20 0.32
CYP1A2 P05177 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11868810 0.97 CHRNB2 (0.38) CHRNB2CHRNB4CHRNA3CHRNA4MEN1
SCHEMBL2204113 0.97
SCHEMBL9308707 0.97
SCHEMBL7680464 0.86
SCHEMBL1072392 0.86 MEN1 (0.30) MEN1KMT2ALMNA
SCHEMBL23872301 0.83 HRH3 (0.43) CHRNB2CHRNB4CHRNA3CHRNA4MEN1
SCHEMBL7227482 0.83 HRH3 (0.43) CHRNB2CHRNB4CHRNA3CHRNA4MEN1
SCHEMBL10748748 0.83 HRH3 (0.43) CHRNB2CHRNB4CHRNA3CHRNA4MEN1
SCHEMBL23872300 0.80 LTA4H (0.42) CHRNB2CHRNB4CHRNA3CHRNA4MEN1
SCHEMBL11249607 0.78 CXCR4 (0.47) MEN1KMT2AHRH3SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160222014-A1 COMPOUNDS FOR REGULATING FAK AND/OR SRC PATHWAYS ASANA BIOSCIENCES, LLC (US) 2016-08-04 US claimed
WO-2015038417-A1 COMPOUNDS FOR REGULATING FAK AND/OR SRC PATHWAYS ASANA BIOSCIENCES, LLC (US) 2015-03-19 WO claimed
EP-1709142-B1 DETERGENT / ANTI-OXIDANT ADDITIVES FOR FUELS AND LUBRICANTS CHEMTURA CORP (US) 2012-12-26 EP claimed
CN-101035882-B Detergent / anti-oxidant additives for fuels and lubricants CHEMTURA CORP 2012-10-03 CN claimed
JP-4628371-B2 2011-02-09 JP claimed
US-7629300-B2 Detergent / anti-oxidant additives for lubricants CHEMTURA CORPORATION (US) 2009-12-08 US claimed
US-7621971-B2 Detergent/anti-oxidant additives for fuels CHEMTURA CORPORATION (US) 2009-11-24 US claimed
US-7618467-B2 Detergent / anti-oxidant additives for fuels and lubricants CHEMTURA CORPORATION (US) 2009-11-17 US claimed
US-7605284-B2 Process for preparing organically modified polyorganosiloxanes GOLDSCHMIDT GMBH (DE) 2009-10-20 US claimed
US-20090088350-A1 DETERGENT / ANTI-OXIDANT ADDITIVES FOR LUBRICANTS LANXESS CANADA CO./CIE 2009-04-02 US claimed
CN-101035882-A Detergent / anti-oxidant additives for fuels and lubricants CROMPTION CORP (US) 2007-09-12 CN claimed
JP-2007519812-A 2007-07-19 JP claimed
US-20070100153-A1 PROCESS FOR PREPARING ORGANICALLY MODIFIED POLYORGANOSILOXANES GOLDSCHMIDT GMBH (DE) 2007-05-03 US claimed
EP-1709142-A1 DETERGENT / ANTI-OXIDANT ADDITIVES FOR FUELS AND LUBRICANTS CHEMTURA CORPORATION (US) 2006-10-11 EP claimed
US-20050172543-A1 Detergent / anti-oxidant additives for fuels and lubricants LANXESS CANADA CO./CIE 2005-08-11 US claimed
WO-2005073352-A1 DETERGENT / ANTI-OXIDANT ADDITIVES FOR FUELS AND LUBRICANTS CHEMTURA CORPORATION (US) 2005-08-11 WO claimed
US-RE35217-E ALKALINE DEVELOPMENT OF EXPOSED NOVOLAK/O-QUINONEDIAZIDE PHOTORESIST LATENT IMAGE BASF AKTIENGESELLSCHAFT (DE) 1996-04-23 US claimed
EP-0432622-B1 Process for developing photoresists BASF AG (DE) 1996-03-27 EP claimed
EP-0355015-B1 Process for developing positively acting photoresists BASF AG (DE) 1994-01-19 EP claimed
US-5252436-A Process for developing a positive-working photoresist containing poly(p-hydroxystyrene) and sulfonium salt with an aqueous developer containing basic organic compounds BASF AKTIENGESELLSCHAFT (DE) 1993-10-12 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070100153-A1 PROCESS FOR PREPARING ORGANICALLY MODIFIED POLYORGANOSILOXANES ADH1C, ADH1A, SORD CHRNB2 3101/4885CHRNB4 2900/4885CHRNA3 3013/4885
US-20160222014-A1 COMPOUNDS FOR REGULATING FAK AND/OR SRC PATHWAYS SRC, PTK2, FYN CHRNB2 3765/4885CHRNB4 4063/4885CHRNA3 3748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.